British Journal of Cancer · 2023 · 102 citations · 42 references
MedicineOncologyPathologyCancer ImmunologyNeoplasiaTumor MicroenvironmentCheckpoint Inhibitor TherapyEsophageal CancerImmune Checkpoint InhibitorsLymphoid NeoplasmsLymphoid TissueSquamous Cell CarcinomaCytotoxic T-lymphocyte-associated Protein 4 InhibitorsLymphoid Neoplasm PrognosisLymphoid Tissue ArchitectureLymphoid Tissue OrganizationMucosal Lymphoid TissuesNeoplastic Lymphoid DifferentiationResistance To Checkpoint InhibitorsTertiary Lymphoid Structures
Abstract Background Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). Methods In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody. Results Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138 + plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival. Conclusion The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients.
42
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo et al. · Science · 2006 · 6.5K citations
Medicine, Immunology, Oncology +17
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita, Martin Lauss, Adriana Sanna et al. · Nature · 2020 · 2.3K citations · Full text
Medicine, Immunology, Oncology +12